Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes
Authors:
- Nicolas NovitzkyNNNicolas Novitzky
- Regana MohamedRMRegana Mohamed
- Jill FinlaysonJFJill Finlayson
- Cecile du ToitCTCecile du Toit
- 1 August 2000
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 28 (8) , 941-949
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosisEuropean Journal of Haematology, 1999
- Tumor Necrosis Factor-α Levels Decrease with Anticytokine Therapy in Patients with Myelodysplastic SyndromesJournal of Interferon & Cytokine Research, 1998
- Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapyBritish Journal of Haematology, 1995
- The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS)British Journal of Haematology, 1995
- Hematopoietic Growth Factor Therapy of Myelodysplastic SyndromesLeukemia & Lymphoma, 1993
- Responsiveness of bone marrow erythropoietic stem cells (CFU‐E and BFU‐E) to recombinant human erythropoietin (rh‐Ep) in vitro in aplastic anemia and myelodysplastic syndromeAmerican Journal of Hematology, 1990
- Circulating erythropoietin in patients with myelodysplastic syndromesBritish Journal of Haematology, 1989
- ANTILYMPHOCYTE GLOBULIN FOR MYELODYSPLASTIC SYNDROME?British Journal of Haematology, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Conditions controlling the proliferation of haemopoietic stem cells in vitroJournal of Cellular Physiology, 1977